Entera Bio Ltd. (ENTX) vs KORU Medical Systems, Inc. (KRMD)
A side-by-side comparison of Entera Bio Ltd. and KORU Medical Systems, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENTX
Entera Bio Ltd.
$2.53HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
KRMD
KORU Medical Systems, Inc.
$3.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ENTX vs KRMD
growth of $100 · dividends reinvested · last 8yENTX -58.3% (-10.4%/yr)KRMD +155.1% (+12.4%/yr)KRMD compounded faster over this window
Log scale — wide-divergence pair
ENTX KRMD
ENTX vs KRMD: by the numbers
- •KRMD is the larger company ($138M vs $125M market cap).
- •Both run net losses; KRMD's is the smaller (-4.03% vs -27235.71% net margin).
Metrics side by side
Valuation
| Metric | ENTX | KRMD |
|---|---|---|
| P/S ratio | N/A | 3.05 |
| P/B ratio | 17.16 | 7.63 |
| FCF yield | N/A | 0.19% |
Profitability
| Metric | ENTX | KRMD |
|---|---|---|
| Gross margin | 0.00% | 61.99% |
| Operating margin | -27450.00% | -3.66% |
| Net margin | -27235.71% | -4.03% |
| ROE | -234.42% | -10.08% |
| ROIC | -82.87% | -7.95% |
Growth (annualized)
| Metric | ENTX | KRMD |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 16.42% |
| Total return CAGR (5Y) | -10.57% | 1.60% |
Frequently asked
- How have ENTX and KRMD total returns compared?
- Over the past 5 years, ENTX delivered -10.57% and KRMD delivered 1.60% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Entera Bio ROEKORU Medical Systems ROEEntera Bio operating marginKORU Medical Systems operating marginEntera Bio revenue growthKORU Medical Systems revenue growthEntera Bio free cash flowKORU Medical Systems free cash flow
Entera Bio & KORU Medical Systems appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.